Balance Sheet - MoonLake Immunotherapeutics (MLTX)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | |
|---|---|---|---|---|---|---|
| Total cash and short-term investments | 393.97 | 448.03 | 511.01 | 72.11 | 8.04 | 1.34 |
| Accounts receivable, net | 4.87 | 2.84 | 1.06 | 0.22 | 0.15 | |
| Inventories | 1.32 | |||||
| Other current assets | 22.86 | 23.42 | 2.10 | 4.18 | 1.45 | 0.28 |
| Total current assets | 421.69 | 474.29 | 514.17 | 76.51 | 9.64 | 1.62 |
| Total non-current assets | 2.74 | 3.64 | 12.37 | 0.33 | 0.05 | 115.01 |
| Total assets | 424.43 | 477.93 | 526.54 | 76.84 | 9.68 | 116.63 |
| Total current liabilities | 45.48 | 22.46 | 9.97 | 7.67 | 21.09 | 0.13 |
| Total non-current liabilities | 74.47 | 2.08 | 3.08 | 0.41 | 0.24 | 4.03 |
| Total liabilities | 119.95 | 24.54 | 13.05 | 8.08 | 21.33 | 4.15 |
| Total stockholders' equity | 304.48 | 446.83 | 495.68 | 48.90 | -11.65 | 112.48 |
| Common shares outstanding | 64 | 63 | 49 | 29 | 37 | 15 |
Show Quarterly Balance Sheet
Balance Sheet - MoonLake Immunotherapeutics (MLTX)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 357.92 | 393.97 | 380.48 | 425.08 | 480.13 | 448.03 | 493.92 | 519.80 | 547.05 | 511.01 | 495.98 | 501.79 | 63.05 | 72.11 | 83.46 | 92.71 | 101.02 | 8.04 | 1.03 | 1.10 | 116.18 | 0.00 |
| Accounts receivable, net | 5.76 | 4.87 | 4.02 | 3.41 | 2.99 | 2.84 | 2.41 | 1.68 | 1.50 | 1.06 | 0.72 | 0.62 | 0.38 | 0.22 | 0.60 | 0.56 | 15.00 | 0.15 | 0.07 | |||
| Other current assets | 32.96 | 22.86 | 26.71 | 26.99 | 23.15 | 23.42 | 15.98 | 15.41 | 5.04 | 2.10 | 3.31 | 3.96 | 3.08 | 4.18 | 4.48 | 5.11 | 0.14 | 1.45 | 0.18 | 0.23 | 0.29 | |
| Total current assets | 396.64 | 421.69 | 411.22 | 455.48 | 506.26 | 474.29 | 512.32 | 536.88 | 553.59 | 514.17 | 500.01 | 506.37 | 66.50 | 76.51 | 88.54 | 98.38 | 116.16 | 9.64 | 1.21 | 1.33 | 1.46 | |
| Total non-current assets | 3.73 | 2.74 | 3.12 | 4.62 | 5.00 | 3.64 | 5.90 | 8.00 | 10.53 | 12.37 | 0.21 | 0.25 | 0.29 | 0.33 | 0.05 | 0.06 | 115.05 | 0.05 | 115.04 | 115.04 | 115.03 | |
| Total assets | 400.37 | 424.43 | 414.34 | 460.10 | 511.26 | 477.93 | 518.21 | 544.88 | 564.12 | 526.54 | 500.22 | 506.62 | 66.80 | 76.84 | 88.59 | 98.43 | 231.21 | 9.68 | 116.25 | 116.37 | 116.49 | |
| Total current liabilities | 46.11 | 45.48 | 48.37 | 27.36 | 23.98 | 22.46 | 20.08 | 12.28 | 8.91 | 9.97 | 10.31 | 7.13 | 7.28 | 7.67 | 6.02 | 3.86 | 202.79 | 21.09 | 2.06 | 0.09 | 0.06 | |
| Total non-current liabilities | 100.24 | 74.47 | 74.78 | 74.79 | 74.70 | 2.08 | 2.63 | 2.56 | 2.82 | 3.08 | 0.27 | 0.38 | 0.41 | 0.41 | 0.00 | 0.02 | 4.03 | 0.24 | 4.03 | 4.03 | 4.03 | |
| Total liabilities | 146.35 | 119.95 | 123.14 | 102.15 | 98.68 | 24.54 | 22.71 | 14.85 | 11.73 | 13.05 | 10.58 | 7.51 | 7.68 | 8.08 | 6.02 | 3.88 | 206.82 | 21.33 | 6.08 | 4.12 | 4.09 | |
| Total stockholders' equity | 254.02 | 304.48 | 288.91 | 353.73 | 407.52 | 446.83 | 488.20 | 520.66 | 542.55 | 495.68 | 424.93 | 489.80 | 42.00 | 48.90 | 55.29 | 63.51 | 24.40 | -11.65 | 110.16 | 112.26 | 112.41 | |
| Common shares outstanding | 71 | 64 | 63 | 63 | 63 | 63 | 63 | 63 | 63 | 60 | 54 | 44 | 39 | 39 | 37 | 35 | 37 | 37 | 37 | 37 | 15 | 15 |